Company Filing History:
Years Active: 2020
Title: Xinxin Wen: Innovator in Ophthalmic Biotechnology
Introduction
Xinxin Wen is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of ophthalmic biotechnology, particularly in the development of treatments for cataracts. His innovative work has led to the creation of a unique pharmaceutical compound that shows promise in improving drug efficacy.
Latest Patents
Xinxin Wen holds 1 patent for a lanosterol prodrug compound and its preparation method. This patent discloses a lanosterol prodrug compound, a pharmaceutically acceptable salt, and an isomer thereof. The pharmaceutical composition comprising the lanosterol prodrug compound is intended for use in treating cataracts. Notably, this compound exhibits better permeability than lanosterol, enhancing its potential effectiveness in therapeutic applications.
Career Highlights
Throughout his career, Xinxin Wen has worked with several esteemed institutions. He has been associated with the Zhongshan Ophthalmic Center and Sun Yat-sen University, where he has contributed to various research initiatives. Additionally, he has collaborated with Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd., furthering his impact in the field of ophthalmology.
Collaborations
Xinxin Wen has collaborated with notable colleagues, including Yizhi Liu and Yandong Wang. Their combined expertise has fostered advancements in ophthalmic research and development.
Conclusion
Xinxin Wen's innovative contributions to ophthalmic biotechnology, particularly through his patent for a lanosterol prodrug compound, highlight his role as a key inventor in the field. His work continues to pave the way for new treatments for cataracts, showcasing the importance of innovation in healthcare.